添加微信 添加微信
添加微信
首页: 全球医药政策

新西兰-GreenLight Clinical

时间:2021-10-21 12:03:24 来源:康安医药咨询 作者:康安医药咨询

GreenLight Clinical is internationally recognised by sponsors and investigators as a Physician-led CRO of choice in Ophthalmic & Early-Phase Research. As a full-service CRO, we help customers bring innovative treatments and medical devices to market, with speed and quality in equal measure. We have the investigator network, the right people, in the right roles, at the right time, to get things done. Being a privately held, Australian-owned medium sized business, GreenLight Clinical is agile and pivots quickly to respond to changing client needs or research scope. We provide personalised customer service. Sponsors and Investigators have one point of contact and transparency throughout development. With wide-ranging expertise in numerous therapeutic areas, we pride ourselves on offering customised solutions, supported by the latest in technology. Dr Andrew Chang is our founder, a pre-eminent vitreal retinal surgeon, medical retinal expert in Australia and APAC. We are also the only Australian CRO with its own NATA accredited World Class Central Laboratory based in Sydney’s CBD.

E-mail: sam.adamson@greenlightclinical.com
Web: https://greenlightclinical.com/
Add:134 William Street, Woolloomooloo, NSW 2011

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章